Learn More
Medchemexpress LLC Protac EGFR degrader 4 | 2882845-50-1 | 99.7% | 995.29 | C55H70N12O4S | 5 MG

Supplier: Medchemexpress LLC HY1463495MG
PROTAC designed to selectively target and induce degradation of mutant forms of the epidermal growth factor receptor (EGFR). Demonstrates potent degradation of EGFRdel19 and EGFRL858R/T790M in cellular assays and inhibits growth of EGFR-driven cancer cell lines. Supplied as a high-purity research reagent with recommended solvent and storage conditions.
- Targets mutant EGFR, inducing degradation of activating and resistance variants.
- Demonstrated cellular potency with low-nanomolar DC50 values.
- High reported purity suitable for biochemical and cellular studies.
- Soluble in DMSO at 100 mg/mL; may require ultrasonic treatment.
- Store protected from light and under inert atmosphere; in solvent: -80°C (6 months), -20°C (1 month).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.